Expert Interview
A look at GRAIL's multi-cancer early detection Galleri Test and the results from the SYMPLIFY study presented at ASCO.
Ticker(s): ILMNInstitution: Marcus Foundation
- Medical director and Chief Science Officer of the Marcus Foundation
- Ordered the Galleri Test over 30 times
- Research interest in prostate cancer, having invented GM-CSF genetically engineered vaccines for prostate cancer and took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
